- Home
- PROK vs ZH Comparison
PROK vs ZH Comparison
Compare PROK & ZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- ZH
- Stock Information
- Founded
- PROK 2015
- ZH 2011
- Country
- PROK United States
- ZH China
- Employees
- PROK N/A
- ZH N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- ZH Business Services
- Sector
- PROK Health Care
- ZH Consumer Discretionary
- Exchange
- PROK Nasdaq
- ZH Nasdaq
- Market Cap
- PROK 384.2M
- ZH 365.1M
- IPO Year
- PROK N/A
- ZH 2021
- Fundamental
- Price
- PROK $2.35
- ZH $4.22
- Analyst Decision
- PROK Buy
- ZH Strong Buy
- Analyst Count
- PROK 5
- ZH 1
- Target Price
- PROK $6.25
- ZH $4.70
- AVG Volume (30 Days)
- PROK 3.3M
- ZH 216.4K
- Earning Date
- PROK 08-12-2025
- ZH 08-27-2025
- Dividend Yield
- PROK N/A
- ZH N/A
- EPS Growth
- PROK N/A
- ZH N/A
- EPS
- PROK N/A
- ZH N/A
- Revenue
- PROK $527,000.00
- ZH $464,095,225.00
- Revenue This Year
- PROK $105.79
- ZH N/A
- Revenue Next Year
- PROK N/A
- ZH $7.46
- P/E Ratio
- PROK N/A
- ZH N/A
- Revenue Growth
- PROK N/A
- ZH N/A
- 52 Week Low
- PROK $0.46
- ZH $3.03
- 52 Week High
- PROK $7.13
- ZH $6.32
- Technical
- Relative Strength Index (RSI)
- PROK 43.77
- ZH 46.13
- Support Level
- PROK $2.16
- ZH $4.14
- Resistance Level
- PROK $2.46
- ZH $4.35
- Average True Range (ATR)
- PROK 0.34
- ZH 0.15
- MACD
- PROK -0.16
- ZH -0.03
- Stochastic Oscillator
- PROK 7.14
- ZH 35.64
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About ZH Zhihu Inc. (every two of each representing one ordinary share)
Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.